Sanofi Deal-Making Aimed At Changing Oncology R&D, Zerhouni Says
This article was originally published in The Pink Sheet Daily
The French drug maker announced deals with Warp Drive Bio and Innate Pharma on the opening day of J.P. Morgan, research collaborations intended to reenergize the company’s come-from-behind position in oncology.
You may also be interested in...
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.
US vaccination campaign will pick up speed now that access is broadening, leaders from Operation Warp Speed, Pfizer, Moderna, McKesson and CVS Health say at a J.P. Morgan panel discussion.
Vir believes its single antibody will be effective against rising mutant forms of COVID-19. Phase III data from two ongoing trials are expected in the first quarter.